Wentworth, John M.
,
Bediaga, Naiara G.
Giles, Lynne C.
Ehlers, Mario
Gitelman, Stephen E.
Geyer, Susan
Evans-Molina, Carmella
Harrison, Leonard C.
,
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK061010, U01 DK061034, U01 DK061042, U01 DK06)
Juvenile Diabetes Research Foundation International (2-SRA-2018-609-Q-R)
National Health and Medical Research Council (Program Grant 1037321 and CRE 1078106)
Juvenile Diabetes Research Foundation Australia
Article History
Received: 20 June 2018
Accepted: 1 August 2018
First Online: 30 August 2018
Duality of interest
: SEG received funding from the Immune Tolerance Network (in turn funded by NIAID) for his role as principal investigator of the START trial (ITN-28). SG received a grant from NIDDK for unrelated work. All other authors declare that there is no duality of interest associated with their contribution to this manuscript.
Free to read: This content has been made available to all.